Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4345-03-3

Post Buying Request

4345-03-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4345-03-3 Usage

Description

Tocopherol succinate (4345-03-3) is a potent antioxidant. Protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor.1,2?Tocopherol succinate induces apoptosis in human gastric cancer cells3?and inhibits proliferation of mesothelioma cells by down-regulation of fibroblast growth factor receptor-14. Induces apoptosis in neuroblastoma cells.5

Chemical Properties

Off-White to Pale Yellow Solid

Uses

Different sources of media describe the Uses of 4345-03-3 differently. You can refer to the following data:
1. A potent antioxidant tocopherol
2. A potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand). It inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Furthermore, it has been shown to enhance the anti-tumor effect of dendritic cell vaccines.
3. A potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand). It inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Furthermore, it has been shown to enhance the anti-tumor effect of dendritic cell vaccines.

General Description

White powder.

Air & Water Reactions

Insoluble in water.

Reactivity Profile

Vitamin E succinate is an ester. Esters react with acids to liberate heat along with alcohols and acids. Strong oxidizing acids may cause a vigorous reaction that is sufficiently exothermic to ignite the reaction products. Heat is also generated by the interaction of esters with caustic solutions. Flammable hydrogen is generated by mixing esters with alkali metals and hydrides.

Fire Hazard

Flash point data for Vitamin E succinate are not available; however, Vitamin E succinate is probably combustible.

Flammability and Explosibility

Notclassified

Biochem/physiol Actions

Tocopherol exhibits antioxidant property by protecting the cells and membranes from oxidative stress. In plants, high levels of α-tocopherol leads to plant stress tolerance whereas low levels is associated with oxidative stress. In humans, tocopherol prevents cancer, premature aging, atherosclerosis, arthritis caused due to free radicals. Vitamin E succinate (VES) is an anti-tumor analog of vitamin E.

Safety Profile

When heated to decomposition it emits acrid smoke and irritating fumes.

References

1) Singh?et al. (2010),?Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor; Int. J. Radiation Biol.,?86?12 2) Singh?et al. (2009),?Tocopherol succinate: a promising radiation countermeasure; Immunopharmacol.,?9?1423 3) Wu?et al. (2004),?c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells; J. Gastroenterol.,?10?1110 4) Stapelberg?et al. (2004),?alpha-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors; Biochem. Biophys. Res. Commun.,?318?636 5) Swettenham?et al. (2005),?Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system; J. Neurochem.,?94?1448

Check Digit Verification of cas no

The CAS Registry Mumber 4345-03-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,4 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 4345-03:
(6*4)+(5*3)+(4*4)+(3*5)+(2*0)+(1*3)=73
73 % 10 = 3
So 4345-03-3 is a valid CAS Registry Number.
InChI:InChI=1/C33H54O5/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-20-33(8)21-19-28-27(7)31(25(5)26(6)32(28)38-33)37-30(36)18-17-29(34)35/h22-24H,9-21H2,1-8H3,(H,34,35)/t23-,24-,33-/m1/s1

4345-03-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T2628)  D-α-Tocopherol Succinate  >97.0%(GC)(T)

  • 4345-03-3

  • 5g

  • 420.00CNY

  • Detail
  • TCI America

  • (T2628)  D-α-Tocopherol Succinate  >97.0%(GC)(T)

  • 4345-03-3

  • 25g

  • 1,380.00CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1029)    pharmaceutical secondary standard; traceable to USP and PhEur

  • 4345-03-3

  • PHR1029-500MG

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (T1610000)  RRR-α-Tocopherylhydrogensuccinate  European Pharmacopoeia (EP) Reference Standard

  • 4345-03-3

  • T1610000

  • 1,880.19CNY

  • Detail
  • USP

  • (1667803)  Alphatocopherylacidsuccinate  United States Pharmacopeia (USP) Reference Standard

  • 4345-03-3

  • 1667803-250MG

  • 4,662.45CNY

  • Detail
  • Supelco

  • (47782)  D-α-Tocopherolsuccinate  analytical standard

  • 4345-03-3

  • 000000000000047782

  • 300.69CNY

  • Detail
  • Sigma

  • (95255)  D-α-Tocopherolsuccinate  BioXtra, ≥98.0% (HPLC)

  • 4345-03-3

  • 95255-100MG

  • 2,163.33CNY

  • Detail
  • Sigma

  • (T3126)  D-α-Tocopherolsuccinate  semisynthetic, 1210 IU/g

  • 4345-03-3

  • T3126-5G

  • 423.54CNY

  • Detail
  • Sigma

  • (T3126)  D-α-Tocopherolsuccinate  semisynthetic, 1210 IU/g

  • 4345-03-3

  • T3126-25G

  • 1,064.70CNY

  • Detail
  • Sigma

  • (T3126)  D-α-Tocopherolsuccinate  semisynthetic, 1210 IU/g

  • 4345-03-3

  • T3126-100G

  • 3,280.68CNY

  • Detail

4345-03-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name α-Tocopheryl Succinate

1.2 Other means of identification

Product number -
Other names D-α-Tocopherol succinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4345-03-3 SDS

4345-03-3Synthetic route

succinic acid anhydride
108-30-5

succinic acid anhydride

Tocopherol
59-02-9

Tocopherol

vitamin E succinate
4345-03-3

vitamin E succinate

Conditions
ConditionsYield
With pyridine; dmap at 25℃;94%
With sodium hydroxide In butanone at 40℃; for 6h; Reagent/catalyst; Temperature; Solvent;93.6%
dmap; triethylamine In dichloromethane at 25℃;85%
succinic acid
110-15-6

succinic acid

Tocopherol
59-02-9

Tocopherol

vitamin E succinate
4345-03-3

vitamin E succinate

Conditions
ConditionsYield
Stage #1: succinic acid With dicyclohexyl-carbodiimide; dmap In dichloromethane for 0.166667 - 0.25h; Ultrasonication;
Stage #2: Tocopherol In dichloromethane at 25℃;
73%
delta tocopherol
119-13-1

delta tocopherol

vitamin E succinate
4345-03-3

vitamin E succinate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: durch Chlormethylierung und Reduktion
2: pyridine
View Scheme
5,8-dimethyltocol
16698-35-4

5,8-dimethyltocol

vitamin E succinate
4345-03-3

vitamin E succinate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: durch Chlormethylierung und Reduktion
2: pyridine
View Scheme
1-azido-5-aminopentane
148759-41-5

1-azido-5-aminopentane

vitamin E succinate
4345-03-3

vitamin E succinate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 4-((5-azidopentyl)amino)-4-oxobutanoate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl 4-((5-azidopentyl)amino)-4-oxobutanoate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃;100%
2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethanol
86770-67-4

2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethanol

vitamin E succinate
4345-03-3

vitamin E succinate

2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl ((R)2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl ((R)2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;99%
2,2'-iminobis[ethanol]
111-42-2

2,2'-iminobis[ethanol]

vitamin E succinate
4345-03-3

vitamin E succinate

(2-hydroxyethyl)ammonium 4-oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy]butanoate

(2-hydroxyethyl)ammonium 4-oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy]butanoate

Conditions
ConditionsYield
In tetrahydrofuran; ethyl acetate at 20 - 25℃;98%
8-(1-hydroxyethyl)-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione
32086-89-8

8-(1-hydroxyethyl)-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione

vitamin E succinate
4345-03-3

vitamin E succinate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl (1-(1,3,7trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)ethyl) succinate

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl (1-(1,3,7trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)ethyl) succinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 3h;96%
3-(4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol
371935-74-9

3-(4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol

vitamin E succinate
4345-03-3

vitamin E succinate

α-tocopheryl hemisuccinate
1514918-69-4

α-tocopheryl hemisuccinate

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; 4-(dimethylamino)pyridinium tosylate In 1-methyl-pyrrolidin-2-one; dichloromethane at 20℃; for 19h;95%
vitamin E succinate
4345-03-3

vitamin E succinate

d-α-tocopherol succinic acid calcium salt

d-α-tocopherol succinic acid calcium salt

Conditions
ConditionsYield
With calcium hydroxide In methanol at 58 - 60℃; for 2h; Product distribution / selectivity;94.73%
With calcium oxide In methanol at 28 - 60℃; for 2h; Product distribution / selectivity;88.18%
With calcium carbonate In methanol at 58 - 60℃; for 2h; Product distribution / selectivity;76.36%
With calcium carbonate In Carbon dioxide at 120℃; under 228015 Torr; for 1h; Reaction medium: CO2 as a supercritical fluid;
4-amino-2,2,6,6-tetramethyl-1-piperidine-1-oxyl
14691-88-4

4-amino-2,2,6,6-tetramethyl-1-piperidine-1-oxyl

vitamin E succinate
4345-03-3

vitamin E succinate

1-oxyl-2,2,6,6-tetramethylpiperidine-4-ammonium 4-oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy]butanoate

1-oxyl-2,2,6,6-tetramethylpiperidine-4-ammonium 4-oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yloxy]butanoate

Conditions
ConditionsYield
In tetrahydrofuran; ethyl acetate at 20 - 25℃;93%
doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

vitamin E succinate
4345-03-3

vitamin E succinate

C60H81NO15
1515877-13-0

C60H81NO15

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 55℃; for 24h;88%
vitamin E succinate
4345-03-3

vitamin E succinate

Propargylamine
2450-71-7

Propargylamine

C36H57NO4

C36H57NO4

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; for 16h;87.144%
vitamin E succinate
4345-03-3

vitamin E succinate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

A

vitamin E succinic acid pyroglutamate conjugate

vitamin E succinic acid pyroglutamate conjugate

B

N-methylmorpholine hydrochloride
3651-67-0

N-methylmorpholine hydrochloride

Conditions
ConditionsYield
Stage #1: vitamin E succinate With 4-methyl-morpholine; isobutyl chloroformate In tetrahydrofuran at 0 - 20℃; for 1.75h;
Stage #2: L-Pyroglutamic acid With triethylamine In tetrahydrofuran; DMF (N,N-dimethyl-formamide); water at 0 - 20℃;
Stage #3: With hydrogenchloride In dichloromethane; water
A 87%
B n/a
vitamin E succinate
4345-03-3

vitamin E succinate

2'-O-(4''-O-tocopherylsuccinoyl)paclitaxel
850655-07-1

2'-O-(4''-O-tocopherylsuccinoyl)paclitaxel

Conditions
ConditionsYield
Stage #1: vitamin E succinate With thionyl chloride In toluene at 20 - 50℃;
Stage #2: taxol With triethylamine In tetrahydrofuran at 20℃;
84.6%
With dmap; diisopropyl-carbodiimide In chloroform at 20℃;
With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride
bromoacetic acid tert-butyl ester
5292-43-3

bromoacetic acid tert-butyl ester

vitamin E succinate
4345-03-3

vitamin E succinate

3-(D-α-tocopheryloxycarbonyl)propionyloxyacetic acid
1384115-80-3

3-(D-α-tocopheryloxycarbonyl)propionyloxyacetic acid

Conditions
ConditionsYield
Stage #1: vitamin E succinate With tetra(n-butyl)ammonium hydroxide In water
Stage #2: bromoacetic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one at 0℃; for 1h; Inert atmosphere;
Stage #3: With triethylsilane; trifluoroacetic acid In 1-methyl-pyrrolidin-2-one; dichloromethane at 23℃; for 1.2h; Inert atmosphere;
84%
7-ethyl-10-hydroxycamptothecin
86639-52-3, 110714-48-2, 130144-34-2

7-ethyl-10-hydroxycamptothecin

vitamin E succinate
4345-03-3

vitamin E succinate

tocopherol succinate 7-ethyl-10-hydroxycamptothecin

tocopherol succinate 7-ethyl-10-hydroxycamptothecin

Conditions
ConditionsYield
Stage #1: vitamin E succinate With thionyl chloride In toluene at 20℃; for 24h;
Stage #2: 7-ethyl-10-hydroxycamptothecin With triethylamine In methylene chloride; N,N-dimethyl acetamide at 20℃; for 1470h; Product distribution / selectivity;
83.9%
Stage #1: 7-ethyl-10-hydroxycamptothecin; vitamin E succinate In 1-methyl-pyrrolidin-2-one; dichloromethane for 0.0833333h; Sonication; Cooling with ice;
Stage #2: With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; 4-(dimethylamino)pyridinium tosylate at 20℃; for 2.16667h;
80%
With pyridine; dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 25℃;70%
Stage #1: vitamin E succinate With thionyl chloride In toluene at 20 - 50℃;
Stage #2: 7-ethyl-10-hydroxycamptothecin With triethylamine In tetrahydrofuran at 20℃; Product distribution / selectivity;
57.2%
vitamin E succinate
4345-03-3

vitamin E succinate

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

tocopheryl ascorbyl succinate

tocopheryl ascorbyl succinate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide; dmap In tetrahydrofuran; ethyl acetate at 25℃; for 8h;81%
17-azido-3,6,9,12,15-pentaoxaheptadecan-1-ol
86770-69-6

17-azido-3,6,9,12,15-pentaoxaheptadecan-1-ol

vitamin E succinate
4345-03-3

vitamin E succinate

17-azido-3,6,9,12,15-pentaoxaheptadecyl ((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

17-azido-3,6,9,12,15-pentaoxaheptadecyl ((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;78%
2-((2-hydroxyethyl)disulfanyl) ethyl methacrylate
1205532-50-8

2-((2-hydroxyethyl)disulfanyl) ethyl methacrylate

vitamin E succinate
4345-03-3

vitamin E succinate

C41H66O7S2

C41H66O7S2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; Darkness;73%
vitamin E succinate
4345-03-3

vitamin E succinate

succinic acid 3,4-dihydro-5-nitromethyl-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl monoester

succinic acid 3,4-dihydro-5-nitromethyl-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl monoester

Conditions
ConditionsYield
With nitric acid; acetic acid at 20℃; for 0.5h;68%
vitamin E succinate
4345-03-3

vitamin E succinate

resquimod
144875-48-9

resquimod

C50H74N4O6

C50H74N4O6

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 15h; Inert atmosphere;67%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 15h; Inert atmosphere;67%
vitamin E succinate
4345-03-3

vitamin E succinate

glycine-phenylananine-leucine-glycine
104845-49-0

glycine-phenylananine-leucine-glycine

C52H80N4O9

C52H80N4O9

Conditions
ConditionsYield
Stage #1: vitamin E succinate With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dimethyl sulfoxide for 2h;
Stage #2: glycine-phenylananine-leucine-glycine In dimethyl sulfoxide at 20℃; for 24h;
63%
ethylenediamine
107-15-3

ethylenediamine

vitamin E succinate
4345-03-3

vitamin E succinate

C35H60N2O4

C35H60N2O4

Conditions
ConditionsYield
Stage #1: vitamin E succinate With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 20h;
Stage #2: ethylenediamine In dimethyl sulfoxide at 20℃; for 24h;
60%
camptothecin
7689-03-4

camptothecin

vitamin E succinate
4345-03-3

vitamin E succinate

tocopherol succinate camptothecin

tocopherol succinate camptothecin

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In N,N-dimethyl acetamide at 20 - 50℃; for 28h;55.2%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

vitamin E succinate
4345-03-3

vitamin E succinate

tocopherol succinate 10-hydroxycamptothecin

tocopherol succinate 10-hydroxycamptothecin

Conditions
ConditionsYield
Stage #1: vitamin E succinate With thionyl chloride In toluene at 20 - 50℃; for 24h;
Stage #2: (S)-10-hydroxycamptothecin With triethylamine In methylene chloride; N,N-dimethyl acetamide at 20℃; for 24.0833h; Product distribution / selectivity;
52.5%
Stage #1: vitamin E succinate With thionyl chloride In toluene at 20 - 50℃;
Stage #2: (S)-10-hydroxycamptothecin With triethylamine In tetrahydrofuran at 20℃; Product distribution / selectivity;
48.4%
etoposide
33419-42-0

etoposide

vitamin E succinate
4345-03-3

vitamin E succinate

C62H84O17
1514918-68-3

C62H84O17

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; 4-(dimethylamino)pyridinium tosylate In 1-methyl-pyrrolidin-2-one; dichloromethane at 20℃; for 2.83333h; Cooling with ice;52%
N-succinimydyl 3-(2-pyridyldithio)propionate
68181-17-9

N-succinimydyl 3-(2-pyridyldithio)propionate

vitamin E succinate
4345-03-3

vitamin E succinate

C40H62N2O4S2

C40H62N2O4S2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In chloroform49%
vitamin E succinate
4345-03-3

vitamin E succinate

α-(2-azidoethyl)-ω-hydroxyhexa(oxyethylene)
352439-36-2

α-(2-azidoethyl)-ω-hydroxyhexa(oxyethylene)

23-azido-3,6,9,12,15,18,21-heptaoxatricosyl ((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

23-azido-3,6,9,12,15,18,21-heptaoxatricosyl ((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)succinate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;45%
tocopherol succinate 7-ethyl-10-hydroxycamptothecin

tocopherol succinate 7-ethyl-10-hydroxycamptothecin

vitamin E succinate
4345-03-3

vitamin E succinate

10,20-di(tocopherol succinate) 7-ethyl-10-hydroxycamptothecin

10,20-di(tocopherol succinate) 7-ethyl-10-hydroxycamptothecin

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In 1,4-dioxane at 20℃; for 24h;44.82%
heptacyclo<6.6.0.02,6.03,13.04,11.05,9.010,14>tetradecane-7,12-diol
89302-19-2

heptacyclo<6.6.0.02,6.03,13.04,11.05,9.010,14>tetradecane-7,12-diol

vitamin E succinate
4345-03-3

vitamin E succinate

C47H68O6

C47H68O6

Conditions
ConditionsYield
Stage #1: vitamin E succinate With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.5h; Inert atmosphere;
Stage #2: heptacyclo<6.6.0.02,6.03,13.04,11.05,9.010,14>tetradecane-7,12-diol In N,N-dimethyl-formamide for 18h; Inert atmosphere;
38%
vitamin D3
67-97-0

vitamin D3

vitamin E succinate
4345-03-3

vitamin E succinate

tocopheryl calciferyl succinate

tocopheryl calciferyl succinate

Conditions
ConditionsYield
Stage #1: vitamin E succinate With dicyclohexyl-carbodiimide; dmap In dichloromethane at 20℃; for 0.333333h;
Stage #2: vitamin D3 In dichloromethane at 20℃; for 18h; Absence of light;
35%

4345-03-3Relevant articles and documents

Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E

Abu-Fayyad, Ahmed,Nazzal, Sami

, p. 145 - 156 (2017)

Vitamin E refers to a group of saturated tocopherol (T) isomers and the biologically more active unsaturated tocotrienol (T3) isomers. PEGylated α-tocopherol, commercially known as Vitamin E TPGS, has been used as an emulsifier and therapeutic agent for children with vitamin E deficiency. Limited information, however, is available about the PEG conjugates of the tocotrienol isomers of vitamin E. The current work was therefore undertaken to synthesize and characterize the water soluble polyethylene glycol (PEG 350 and 1000) derivatives of T and T3. Yield and the identity of the synthesized products were confirmed by 1H NMR, mass spectroscopy, HPLC, and thermal analysis. The self-assembly of the PEGylated vitamin E isomers in water at critical micelle concentrations (CMC) was further confirmed by size, zeta, and Cryo-TEM image analysis. While stable at pH 7.4, PEG conjugates were found to rapidly hydrolyze at pH 1.2. Our data showed that PEGylated T3 isomers were significantly more active as inhibitors for P-glycoprotein than PEGylated T. The in vitro cytotoxicity of the conjugates was also tested against a large panel of normal and tumorigenic cells. Of the conjugates, γ-T3PGS 1000 and δ-T3PGS 1000 were found to have the least toxicity against non-tumorigenic breast and pancreatic cell lines, which may be advantageous for its use as functional excipients in drug delivery. The results from the current work have demonstrated the feasibility of synthesizing PEGylated conjugates of vitamin E isomers and highlighted the potential use of these conjugates in drug delivery as functional and safer excipients especially for γ-T3PGS 1000 and δ-T3PGS 1000 conjugate.

Encapsulation of enzymes in metal ion-surfactant nanocomposites for catalysis in highly polar solvents

Cao, Xun,Ni, Yan,Zhang, Alei,Xu, Sheng,Chen, Kequan,Ouyang, Pingkai

, p. 3134 - 3137 (2017)

We described a method to encapsulate enzymes in metal ion-surfactant nanocomposites. The nanobiocatalyst displayed highly retained activity (~100%) and much improved stability in protein-denaturing organic solvents. As a demonstration, the encapsulated lipase exhibited much higher activity and stability in the synthesis of vitamin E succinate in dimethyl sulfoxide.

Method for reducing by hydrolysis producing high content of natural vitamin E industrial production method

-

Paragraph 0039-0040, (2017/03/08)

An industrialized production method for producing high-content natural vitamin E by utilizing a hydrolysis reduction process comprises: (1) dissolving low-content natural mixed tocopherols in proper amount of a solvent, adding succinic anhydride and performing esterification reaction under an alkaline condition, so as to generate corresponding natural tocopherol esters; (2) performing reduced-pressure distillation on the product obtained in the step (1) to remove the solvent, adding an extraction reagent and performing extraction, water washing, crystallization and separation, so as to obtain natural tocopherol succinate with high content; (3) hydrolyzing natural tocopherol succinate obtained in the step (2) under an alkaline condition, and reducing to generate natural tocopherols; and (4) performing extraction, water washing, separation and distillation on the natural tocopherols obtained through hydrolysis in the step (3), so as to obtain the natural vitamin E (mixed tocopherols) with the high content up to 90% or more.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4345-03-3